Axonics Modulation Technologies Inc. (AXNX), which recently made its debut on the NASDAQ, is down nearly 2% so far this month while the iShares Nasdaq Biotechnology ETF index (IBB) has gained nearly 8% for the same period.
from RTT - Biotech http://bit.ly/2TvcVdp
via IFTTT
No comments:
Post a Comment